ABBV ▲ +0.3% - AbbVie Inc. $ABBV APGE - AbbVie Completes Acquisition of Apogee Therapeutics AbbVie completed its acquisition of Apogee Therapeutics, a move that expands the company's portfolio in an undisclosed therapeutic area. The modest 0.3% gain suggests investors digested the deal as a strategic but measured addition to the company's pipeline. 03-SEP-2026 08:35 AM ET